Schonfeld Strategic Advisors’s Akoya BioSciences AKYA Stock Holding History

Schonfeld Strategic Advisors’s Portfolio AKYA Stock Details AKYA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-122,000	Closed	-$279K	–	2180
2024 Q4	$279K	Sell	122,000 -149,400	-55%	-$396K	﹤0.01%	1633
2024 Q3	$738K	Sell	271,400 -22,942	-8%	-$56K	﹤0.01%	1268
2024 Q2	$689K	Sell	294,342 -81,158	-22%	-$259K	﹤0.01%	1354
2024 Q1	$1.76M	Buy	375,500 +219,700	+141%	+$1.14M	0.01%	1037
2023 Q4	$760K	Buy	155,800 +26,300	+20%	+$109K	0.01%	1135
2023 Q3	$602K	Buy	129,500 +7,200	+6%	+$41.4K	﹤0.01%	1158
2023 Q2	$904K	Buy	122,300 +69,900	+133%	+$467K	0.01%	1012
2023 Q1	$429K	Buy	52,400 +12,300	+31%	+$128K	﹤0.01%	1230
2022 Q4	$384K	Buy	+40,100	New	+$493K	﹤0.01%	1677

Other funds holding AKYA

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

BWLSA

Blue Water Life Science Advisors Larkspur, California $125M AUM 91.82% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PAPAIJV

Paragon Associates & Paragon Associates II Joint Venture Dallas, Texas $73.6M AUM 61.93% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

PCA

Peddock Capital Advisors Braintree, Massachusetts $501M AUM 29.8% 1-Year Est. Return

Schonfeld Strategic Advisors's AKYA Position: Q1 2025 in Review

Schonfeld Strategic Advisors sold out of Akoya BioSciences (AKYA) in Q1 2025, closing a stake of 122,000 shares — an estimated $279K sold.

Schonfeld Strategic Advisors first reported a position in AKYA in Q4 2022 and held it in 9 quarters. The position peaked at $1.76M in Q1 2024. 64 funds tracked by Wall St. Rank hold AKYA as of Q1 2025.

Schonfeld Strategic Advisors reported no remaining Akoya BioSciences position as of Q1 2025 after selling out during the quarter.
Schonfeld Strategic Advisors sold 122,000 Akoya BioSciences shares in Q1 2025, an estimated $279K.
Schonfeld Strategic Advisors first reported a position in Akoya BioSciences in Q4 2022 and held it in 9 quarters.
Schonfeld Strategic Advisors's Akoya BioSciences position peaked at $1.76M in Q1 2024.
64 funds tracked by Wall St. Rank held Akoya BioSciences as of Q1 2025.

Based on Schonfeld Strategic Advisors's 13F filing for Q1 2025, filed 15 May 2025.